CTKBCytek Biosciences, Inc.Healthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $4.93 · now $4.93 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, CTKB has typically landed between $3.71 and $6.29 — a range of −24.7% to +27.5% from the issuance price $4.93.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,272 overlapping 1 month windows · 2021-07-23 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($4.93) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where CTKB has typically landed a month from the 2026-09-16 close of $4.93 — the range is history, not a prediction.

$3.71worst · -24.7%$6.29best · +27.5%
  • now $4.93 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $4.79 (-2.8%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $4.24–$5.34
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $3.71–$6.29
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,272 windows spanning 2021-07-23 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-04-24−36.6%−36.6%+1.0%
2025-04-28−35.5%−37.3%+0.0%
2025-04-23−35.0%−35.0%+2.4%
3 best
2023-11-07+72.1%+0.0%+72.1%
2023-11-02+71.6%+0.0%+71.6%
2023-11-01+69.9%+0.0%+69.9%

1,272 overlapping windows · 2021-07-23 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
20%
−6.3%
n=5
Feb
20%
−8.4%
n=5
Mar
0%
−11.5%
n=5
Apr
40%
−0.2%
n=5
May
20%
−13.8%
n=5
Jun
80%
+9.5%
n=5
Jul
80%
+9.1%
n=5
Aug
50%
−1.3%
n=6
Sep
33%
−3.9%
n=6
Oct
60%
−2.0%
n=5
Nov
60%
+22.6%
n=5
Dec
20%
−3.9%
n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$6$3↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

300 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-18Jiang WenbindirectorWithheld for tax20,9565,561,029Form 4
2026-08-18Jiang WenbindirectorWithheld for tax7,0625,524,773Form 4
2026-08-18McCombe William D.officerWithheld for tax5,401134,693Form 4
2026-08-18Jiang WenbindirectorWithheld for tax5,3825,502,833Form 4
2026-08-18McCombe William D.officerWithheld for tax4,392124,045Form 4
2026-08-18Yan MingdirectorWithheld for tax3,4634,821,870Form 4
2026-08-18Jiang WenbindirectorWithheld for tax2,8695,486,115Form 4
2026-08-18McCombe William D.officerWithheld for tax2,111115,386Form 4
2026-08-18Yan MingdirectorWithheld for tax1,7784,802,273Form 4
2026-08-18Yan MingdirectorWithheld for tax1,5014,811,113Form 4
2026-08-18Yan MingdirectorWithheld for tax1,3464,806,452Form 4
2026-08-18Yan MingdirectorOption exercise7,36317,189Form 4
2026-08-18Jiang WenbindirectorOption exercise57,212820,054Form 4
2026-08-18Holder MichaeldirectorOption exercise2,1817,276Form 4
2026-08-18Chin RicharddirectorOption exercise6,10744,790Form 4
2026-08-18MUIR GLENN PdirectorOption exercise3,08652,469Form 4
2026-08-18Jiang WenbindirectorOption exercise29,002299,694Form 4
2026-08-18Jiang WenbindirectorOption exercise22,100139,973Form 4
2026-08-18Jiang WenbindirectorOption exercise11,78127,494Form 4
2026-08-18McCombe William D.officerOption exercise16,049230,042Form 4
2026-08-18McCombe William D.officerOption exercise13,051134,862Form 4
2026-08-18McCombe William D.officerOption exercise6,32044,249Form 4
2026-08-18Yan MingdirectorOption exercise14,220203,835Form 4
2026-08-18Yan MingdirectorOption exercise6,16263,688Form 4
2026-08-18Yan MingdirectorOption exercise5,52534,995Form 4
2026-08-18Holder MichaeldirectorOption exercise2,18162,875Form 4
2026-08-18Chin RicharddirectorOption exercise6,10728,499Form 4
2026-08-18MUIR GLENN PdirectorOption exercise3,0863,086Form 4
2026-08-18Chin RicharddirectorOption exercise6,10728,499Form 4
2026-08-18Yan MingdirectorOption exercise6,1624,812,614Form 4
2026-08-18Yan MingdirectorOption exercise14,2204,825,333Form 4
2026-08-18Yan MingdirectorOption exercise6,1624,812,614Form 4
2026-08-18Yan MingdirectorOption exercise5,5254,807,798Form 4
2026-08-18Yan MingdirectorOption exercise7,3634,804,051Form 4
2026-08-18McCombe William D.officerOption exercise16,049140,094Form 4
2026-08-18McCombe William D.officerOption exercise13,051128,437Form 4
2026-08-18McCombe William D.officerOption exercise6,320117,497Form 4
2026-08-18MUIR GLENN PdirectorOption exercise3,0863,086Form 4
2026-08-18Jiang WenbindirectorOption exercise57,2125,581,985Form 4
2026-08-18Jiang WenbindirectorOption exercise29,0025,531,835Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.